PubMed

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets.

Malyguine A, Strobl SL, Shafer-Weaver KA, Ulderich T, Troke A, Baseler M, Kwak LW, Neelapu SS.

J Transl Med. 2004 Mar 29;2(1):9.PMID: 15050026 [PubMed - as supplied by publisher]Related articlesFree article

New approaches for monitoring CTL activity in clinical trials.

Malyguine A, Strobl S, Zaritskaya L, Baseler M, Shafer-Weaver K.

Adv Exp Med Biol. 2007;601:273-84. Review.PMID: 17713015 [PubMed - indexed for MEDLINE]Related articles

Monitoring of immune responses to CA125 with an IFN-gamma ELISPOT assay.

Schultes BC, Whiteside TL.

J Immunol Methods. 2003 Aug;279(1-2):1-15.PMID: 12969543 [PubMed - indexed for MEDLINE]Related articles

Vaccination with agonist peptide PSA: 154-163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154-163 but failed to induce the reactivity against tumor targets expressing PSA: a phase 2 study in patients with recurrent prostate cancer.

Kouiavskaia DV, Berard CA, Datena E, Hussain A, Dawson N, Klyushnenkova EN, Alexander RB.

J Immunother. 2009 Jul-Aug;32(6):655-66.PMID: 19483644 [PubMed - indexed for MEDLINE]Related articles

T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

Csurhes PA, Sullivan AA, Green K, Pender MP, McCombe PA.

J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1431-9.PMID: 16170091 [PubMed - indexed for MEDLINE]Related articlesFree article

The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity.

Shafer-Weaver K, Sayers T, Strobl S, Derby E, Ulderich T, Baseler M, Malyguine A.

J Transl Med. 2003 Dec 29;1(1):14.PMID: 14697097 [PubMed - as supplied by publisher]Related articlesFree article

Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.

Tang J, Flomenberg P, Harshyne L, Kenyon L, Andrews DW.

Clin Cancer Res. 2005 Jul 15;11(14):5292-9.PMID: 16033848 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination.

Karbach J, Gnjatic S, Pauligk C, Bender A, Maeurer M, Schultze JL, Nadler K, Wahle C, Knuth A, Old LJ, Jäger E.

Int J Cancer. 2007 Nov 1;121(9):2042-8.PMID: 17640060 [PubMed - indexed for MEDLINE]Related articles

MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes.

Mayr C, Bund D, Schlee M, Bamberger M, Kofler DM, Hallek M, Wendtner CM.

Exp Hematol. 2006 Jan;34(1):44-53.PMID: 16413390 [PubMed - indexed for MEDLINE]Related articles

In vivo T-cell immune response against anaplastic lymphoma kinase in patients with anaplastic large cell lymphomas.

Passoni L, Gallo B, Biganzoli E, Stefanoni R, Massimino M, Di Nicola M, Gianni AM, Gambacorti-Passerini C.

Haematologica. 2006 Jan;91(1):48-55.PMID: 16434370 [PubMed - indexed for MEDLINE]Related articlesFree article

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.

Kutscher S, Dembek CJ, Allgayer S, Heltai S, Stadlbauer B, Biswas P, Nozza S, Tambussi G, Bogner JR, Stellbrink HJ, Goebel FD, Lusso P, Tinelli M, Poli G, Erfle V, Pohla H, Malnati M, Cosma A.

AIDS Res Ther. 2008 Oct 6;5:22.PMID: 18837993 [PubMed]Related articlesFree article

Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.

Maccalli C, Di Cristanziano V, Fodale V, Corsi D, D'Agostino G, Petrangeli V, Laurenti L, Guida S, Mazzocchi A, Arienti F, Perrone MP, Castelli C, Rivoltini L, Zagonel V, Tartaglia M, Parmiani G, Belardelli F.

Clin Cancer Res. 2008 Nov 15;14(22):7292-303. Epub 2008 Oct 30.PMID: 18974390 [PubMed - indexed for MEDLINE]Related articlesFree article

Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients.

Xu Y, Theobald V, Sung C, DePalma K, Atwater L, Seiger K, Perricone MA, Richards SM.

J Transl Med. 2008 Oct 22;6:61.PMID: 18945350 [PubMed - indexed for MEDLINE]Related articlesFree article

Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro.

Cai YG, Fang DC, Chen L, Tang XD, Chen T, Yu ST, Luo YH, Xiong Z, Wang DX, Yang SM.

Tumour Biol. 2007;28(4):238-46. Epub 2007 Aug 23.PMID: 17717429 [PubMed - indexed for MEDLINE]Related articles

Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials.

Shafer-Weaver K, Rosenberg S, Strobl S, Gregory Alvord W, Baseler M, Malyguine A.

J Immunother. 2006 May-Jun;29(3):328-35.PMID: 16699376 [PubMed - indexed for MEDLINE]Related articles

Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.

Tuettenberg A, Becker C, Huter E, Knop J, Enk AH, Jonuleit H.

Int J Cancer. 2006 May 15;118(10):2617-27.PMID: 16353138 [PubMed - indexed for MEDLINE]Related articles

[Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer]

You J, Yu JP, Ren XB, Wang CL, Zhang P, Zhang XZ.

Zhonghua Zhong Liu Za Zhi. 2004 Jun;26(6):333-6. Chinese. PMID: 15312341 [PubMed - indexed for MEDLINE]Related articles

Primary tumor cells resected from cancer patients and decorated with a novel form of CD80 protein serve as effective antigen-presenting cells for the induction of autologous T cell immune responses ex vivo.

Singh NP, Miller RW, Yolcu ES, Kilinc MO, Oechsli M, Huseby R, Taylor DD, Perry MT, Larocca RV, Shirwan H.

Hum Gene Ther. 2006 Mar;17(3):334-46.PMID: 16544982 [PubMed - indexed for MEDLINE]Related articles

Vaccination with allogeneic GM-CSF gene-modified lung cancer cells: antitumor activity comparing with that induced by autologous vaccine.

Li H, Jiang HJ, Ma MQ, Wei F, An XM, Ren XB.

Cancer Biother Radiopharm. 2007 Dec;22(6):790-8.PMID: 18158770 [PubMed - indexed for MEDLINE]Related articles

The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation.

van Besouw NM, Zuijderwijk JM, de Kuiper P, Ijzermans JN, Weimar W, van der Mast BJ.

Transplantation. 2005 May 15;79(9):1062-6.PMID: 15880044 [PubMed - indexed for MEDLINE]Related articles